Suppr超能文献

正常受试者对速尿反应的决定因素。

Determinants of response to frusemide in normal subjects.

作者信息

Branch R A, Roberts C J, Homeida M, Levine D

出版信息

Br J Clin Pharmacol. 1977 Apr;4(2):121-7. doi: 10.1111/j.1365-2125.1977.tb00682.x.

Abstract

The pharmacokinetic and diuretic response of frusemide have been investigated in six normal subjects. Frusemide (80 mg) was administered (a) intravenously to unstressed subjects, (b) orally to unstressed subjects, (c) orally to sodium depleted subjects who had received 80 mg oral frusemide 36 h previously followed by a 20 mmol sodium, 160 mmol potassium diet. After i.v. administration, the logarithmic plasma concentration-time curve was biexponential. There was a linear relationship between the frusemide plasma concentration in the β-phase of elimination and the rate of sodium excretion. Urinary clearance of frusemide was 60% of total plasma clearance, similarly recovery of frusemide in the urine over 36 h was 65% of the dose administered. These observations suggested an extrarenal route of elimination. After oral administration there was also a linear relationship between frusemide plasma concentration and rate of sodium excretion. Oral bioavailability estimated from the ratio of the areas under the plasma concentration-time curve (AUC) and urine recovery over 36 h after i.v. and oral administration was approximately 50%, yet the diuretic response was similar. The AUC of the β-phase after i.v. administration was similar to the total AUC after oral administration suggesting that response was related to drug present in a tissue pool rather than in plasma. After sodium depletion, there was no change in frusemide kinetics, however the diuretic response decreased. Once again, there was a significant relationship between plasma concentration and rate of sodium excretion. This relationship during the elimination phase after oral administration to sodium depleted subjects was significantly shifted to the right compared to the elimination phase after oral administration to unstressed subjects, suggesting a change in plasma concentration response. In conclusion, the response to frusemide is determined by the concentration of drug in the tissue comparement. This response is modified by factors controlling sodium homeostasis.

摘要

已在6名正常受试者中研究了速尿的药代动力学和利尿反应。速尿(80毫克)通过以下方式给药:(a) 静脉注射给未应激的受试者;(b) 口服给未应激的受试者;(c) 口服给钠缺乏的受试者,这些受试者在36小时前已口服80毫克速尿,随后采用20毫摩尔钠、160毫摩尔钾的饮食。静脉注射给药后,对数血浆浓度-时间曲线呈双指数。在消除的β期,速尿血浆浓度与钠排泄率之间存在线性关系。速尿的尿清除率为总血浆清除率的60%,同样,36小时内尿中速尿的回收率为给药剂量的65%。这些观察结果提示存在肾外消除途径。口服给药后,速尿血浆浓度与钠排泄率之间也存在线性关系。根据静脉注射和口服给药后血浆浓度-时间曲线下面积(AUC)之比以及36小时内尿回收率估算的口服生物利用度约为50%,但利尿反应相似。静脉注射给药后β期的AUC与口服给药后的总AUC相似,表明反应与组织池中的药物有关,而非与血浆中的药物有关。钠缺乏后,速尿动力学无变化,但利尿反应降低。同样,血浆浓度与钠排泄率之间存在显著关系。与给未应激受试者口服给药后的消除期相比,给钠缺乏受试者口服给药后消除期的这种关系明显右移,提示血浆浓度反应发生了变化。总之,对速尿的反应取决于组织隔室中药物的浓度。这种反应受控制钠稳态的因素调节。

相似文献

1
Determinants of response to frusemide in normal subjects.
Br J Clin Pharmacol. 1977 Apr;4(2):121-7. doi: 10.1111/j.1365-2125.1977.tb00682.x.
6
The diuretic effect of low dosage frusemide--a preliminary investigation.
Curr Med Res Opin. 1972;1(3):134-8. doi: 10.1185/03007997209111157.
7
Diuretic effect and diuretic efficiency after intravenous dosage of frusemide.
Br J Clin Pharmacol. 1990 Feb;29(2):215-9. doi: 10.1111/j.1365-2125.1990.tb03622.x.
8
A relationship between plasma uric acid concentration and the apparent response to frusemide in normal subjects.
Br J Clin Pharmacol. 1975 Aug;2(4):361-2. doi: 10.1111/j.1365-2125.1975.tb02786.x.
9
The influence of age on renal and extrarenal effects of frusemide.
Br J Clin Pharmacol. 1984 Jul;18(1):65-74. doi: 10.1111/j.1365-2125.1984.tb05023.x.
10
Discrepancy between bioavailability as estimated from urinary recovery of frusemide and total diuretic effect.
Br J Clin Pharmacol. 1992 Jul;34(1):47-52. doi: 10.1111/j.1365-2125.1992.tb04106.x.

引用本文的文献

1
Mechanistic Differences between Torsemide and Furosemide.
J Am Soc Nephrol. 2025 Jan 1;36(1):99-107. doi: 10.1681/ASN.0000000000000481. Epub 2024 Aug 28.
2
Continuous Infusion Versus Bolus Injection of Loop Diuretics for Patients With Congestive Heart Failure: A Meta-Analysis.
Cureus. 2023 Feb 8;15(2):e34758. doi: 10.7759/cureus.34758. eCollection 2023 Feb.
5
Changes in spinal inhibitory networks induced by furosemide in humans.
J Physiol. 2014 Jul 1;592(13):2865-79. doi: 10.1113/jphysiol.2013.265314. Epub 2014 May 16.
6
Continuous infusion versus bolus injection of loop diuretics in congestive heart failure.
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD003178. doi: 10.1002/14651858.CD003178.pub3.
7
Furosemide disposition in patients on CAPD.
Eur J Clin Pharmacol. 1995;48(5):385-90. doi: 10.1007/BF00194955.
8
Plasma protein binding and pharmacological response.
Clin Pharmacokinet. 1993 Jun;24(6):435-40. doi: 10.2165/00003088-199324060-00001.
9
Influence of drug formulation on drug concentration-effect relationships.
Clin Pharmacokinet. 1994 Feb;26(2):135-43. doi: 10.2165/00003088-199426020-00006.

本文引用的文献

2
Absorption and excretion of furosemide-S35 in human subjects.
Proc Soc Exp Biol Med. 1966 Oct;123(1):17-22. doi: 10.3181/00379727-123-31391.
5
Furosemide. A clinical evaluation of its diuretic action.
Circulation. 1966 Nov;34(5):910-20. doi: 10.1161/01.cir.34.5.910.
6
Pharmacokinetics of furosemide in normal subjects and functionally anephric patients.
Clin Pharmacol Ther. 1974 Jun;15(6):588-96. doi: 10.1002/cpt1974156588.
7
Pharmacokinetics of orally administered furosemide.
Clin Pharmacol Ther. 1974 Feb;15(2):178-86.
8
[Examples of phase I: diuretics].
Arzneimittelforschung. 1973 Nov;23(11):Suppl:1665-8.
9
Pharmacokinetics and pharmacodynamics of Lasix.
Scott Med J. 1974;19 Suppl 1:5-13. doi: 10.1177/00369330740190S103.
10
Bioavailability of drugs (second of two parts).
N Engl J Med. 1974 Sep 5;291(10):503-6. doi: 10.1056/NEJM197409052911005.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验